title: Heart failure with preserved ejection fraction.
abstract: Heart failure with preserved ejection fraction (HFpEF) has recently emerged as a major cause of cardiovascular morbidity and mortality. Contrary to initial beliefs, HFpEF is now known to be as common as heart failure with reduced ejection fraction (HFrEF) and carries an unacceptably high mortality rate. With a prevalence that has been steadily rising over the past two decades, it is very likely that HFpEF will represent the dominant heart failure phenotype over the coming few years. The scarcity of trials in this semi-discrete form of heart failure and lack of unified enrolment criteria in the studies conducted to date might have contributed to the current absence of specific therapies. Understanding the epidemiological, pathophysiological and molecular differences (and similarities) between these two forms of heart failure is cornerstone to the development of targeted therapies. Carefully designed studies that adhere to unified diagnostic criteria with the recruitment of appropriate controls and adoption of practical end-points are urgently needed to help identify effective treatment strategies.
authors.affiliation: Department of Cardiology, Aswan Heart Centre, Aswan, Egypt.
authors.forename: Ahmed
authors.initials: A
authors.lastname: ElGuindy
authors.affiliation: Harefield Heart Science Centre, National Heart and Lung Institute, Imperial College London, UK.
authors.forename: Magdi H
authors.initials: MH
authors.lastname: Yacoub
keywords: diastolic heart failure; heart failure; heart failure with preserved ejection fraction